|
contact us investor information | |
TeamKyle Cetrulo, Chief Operating Officer Rouzbeh R. Taghizadeh, Ph.D., Chief Scientific Officer Dr. Taghizadeh has spent the past 10 years working to bring stem cell based therapies to clinical practice, with the aim of helping patients suffering from various diseases and cancers. He has extensive knowledge and expertise in adult stem cells, especially human hematopoietic stem cells – the regenerative cells involved in bone marrow and umbilical cord blood transplantations. He obtained his Ph.D. in Stem Cell Bioengineering in 2006 from the Massachusetts Institute of Technology in the laboratory of Dr. James L. Sherley, where he worked towards developing novel technologies to preferentially expand human hematopoietic stem cells ex vivo, a long-standing challenge faced by both researchers and clinicians. Furthermore, he worked towards the discovery of markers that exclusively identify hematopoietic stem cells, an important feat in the field. Dr. Taghizadeh was named Chief Scientific Officer of AuxoCell Laboratories, Inc., after completing his post-doctoral training from the Massachusetts Institute of Technology and the Boston Biomedical Research Institute in 2008. Dr. Taghizadeh has several peer-reviewed publications, including book chapters and patents and has presented at numerous scientific conferences and industrial forums. Prior to obtaining his doctorate, Dr. Taghizadeh obtained his Bachelors of Science in Chemical Engineering from the University of Massachusetts, Amherst in 2000Curtis L. Cetrulo, M.D. Curtis L. Cetrulo, M.D. has a profound passion for stem cells and pursues this passion with the same excitement and energy that he has brought with him at every stage of his career. Since 1984 until 2008, Dr. Cetrulo has been a Professor of Obstetrics and Gynecology at Tufts University School of Medicine. He is one of the two founding members and is the current President of the International Cord Blood Society (ICBS), a non-profit organization founded in 1995. In 1992, he was named the Director of Regional Perinatal Program at New England Medical Center and from 1975-1992, Dr. Cetrulo was the Director of Maternal-Fetal Medicine at St. Margaret's Hospital in Boston. In 1990, Dr. Cetrulo was named the President of Medical Staff at St. Margaret's Hospital. In 1977, Dr. Cetrulo was board certified in Maternal Fetal Medicine. He was the first OB/GYN to be board certified in Maternal Fetal Medicine in Boston, Massachusetts. Dr. Cetrulo completed his Maternal Fetal Medicine fellowship at the University of Southern California Medical Center in Los Angeles, California in 1975. He completed his Obstetrics/Gynecology residency program at the University of Denver in Denver, Colorado in 1973. Dr. Cetrulo graduated from the New Jersey College of Medicine in 1969. He did his undergraduate work at Columbia University (1965) where he was the captain of the 1964 NCAA champion Fencing team.
|
|
||||||||||||||||||||||||
| Home | What is Wharton’s Jelly | The Program | Medical Research | Therapies | About Auxocell Laboratories Cord Blood | Regenerative Medicine | Stem Cell Research | Stem Cell Therapy | Stem Cells AuxoCell Laboratories, Inc. | 245 First St. Suite 1800 | Cambridge, MA 02142 | 617-610-9000 | Sitemap | Kyle.cetrulo@auxocell.com Copyright © 2010 Auxocell Laboratories Inc., All rights reserved |